Helptext

Movies



Company Information

Company NameOncology Venture Sweden AB
Company Idea

"Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development."

Phone+45 21 70 10 49CEOPeter Buhl Jensen
E-mailinfo(snabel-a)oncologyventure(punkt)comChairm. of the BoardDuncan Moore
Homepagehttp://www.oncologyventure.com 

Instrument Information

Full NameOncology VentureShort NameOV
No of shares10,074,794Par Value0.14 SEK
TypeShareISIN codeSE0007157409

Price Information

+/-0.30
%0.80
Latest37.80
High38.10
Low37.50
Volume6,351
Turnover (SEK)239,493
Market Cap (MSEK)381

Orders

VolumeBidAskVolume
26237.8038.401,011
68137.6039.1065
71037.5039.40500
1,07037.0039.80956
35036.5039.90500
14636.1040.2065
7035.9040.50500
1,00035.2040.701,800
1,50035.0040.80625
60034.0041.001,550
  41.50500
  41.70538
  42.00200
  42.501,030
  43.00250
  43.10400
  43.70600
  44.0022
  44.40600
  44.70600

Deals

TimeBuyerSellerPriceVolume
9:05 AMNONAVA37.80496
9:05 AMNONAVA37.80342
9:05 AMMLIAVA37.90658
9:05 AMAVANON38.001,500
9:04 AMAVAAVA38.1040
9:04 AMAVAAVA38.1060
9:00 AMAVAAVA38.1010
9:00 AMNONAVA37.5090
9:00 AMNONINT37.501,240
9:00 AMNONINT37.50600

Scheduled Reports

DateReport
2017-05-08Årsstämma
2017-05-19Delårsrapport ett
2017-08-25Halvårsrapport
2017-11-23Delårsrapport tre
2018-02-09Bokslutskommuniké för 2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se